Answers are grounded in this paper and cite their sources.
This guide provides practical steps to increase awareness of COVID-19 monoclonal antibodies for outpatients, highlighting their importance.
Developed between June 2021- December 2021, this guide aims to provide practical guidance to help clinicians and other key stakeholders increase awareness and access to COVID-19 mAbs for outpatients with mild to moderate SARS-CoV-2 infection.
No takes yet. Share an insight, caveat, or question.
Lum et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: